LATE-ONSET HUNTINGTONS-DISEASE - A CLINICAL AND MOLECULAR STUDY

Citation
Cm. James et al., LATE-ONSET HUNTINGTONS-DISEASE - A CLINICAL AND MOLECULAR STUDY, Age and ageing, 23(6), 1994, pp. 445-448
Citations number
16
Categorie Soggetti
Geiatric & Gerontology
Journal title
ISSN journal
00020729
Volume
23
Issue
6
Year of publication
1994
Pages
445 - 448
Database
ISI
SICI code
0002-0729(1994)23:6<445:LH-ACA>2.0.ZU;2-V
Abstract
Using the Huntington's disease register for South Wales, a total of 86 affected individuals were identified living in the counties of Mid Gl amorgan, South Glamorgan and Gwent, giving a point prevalence rate for Huntington's Disease in South East Wales of 6.2/100000. Only four (4. 7%) of these individuals developed their symptoms after the age of 60 years. A subsequent retrospective search of the register identified a total of 33 individuals with clinical evidence of Huntington's disease and whose age of onset of symptoms occurred between the ages of 60 an d 77 years. In this group the median time for disease duration from th e onset of symptoms was 13 years (range 0.5-25 years), with survival u p to age 86 years recorded. Initial symptoms of Huntington's disease i ncluded disturbance of gait in 32 individuals; 31 had involuntary move ments, and 20 had abnormality of speech. Major psychiatric symptoms we re present in only six cases; but approximately a third (ten cases) ha d symptoms related to impaired cognitive function. Molecular analysis was possible on ten individuals in the series. The expanded CAG repeat sequence in the Huntington's disease gene was found in all cases, wit h a narrow range of 36-38 repeats, representing the smallest repeats s een in our Huntington's disease group. Our study suggests that Hunting ton's disease in elderly people causes predominantly motor disturbance at onset with relatively mild disability and a favourable outlook for both independent living and for life expectancy. However, the potenti al for under-diagnosis in this age group may have considerable genetic consequences, with transmission of the disorder to numerous descendan ts by the time its hereditary nature is recognized.